Los Angeles Capital Management & Equity Research Inc. grew its stake in Masimo Corporation (NASDAQ:MASI) by 49.9% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 97,918 shares of the medical equipment provider’s stock after purchasing an additional 32,575 shares during the period. Los Angeles Capital Management & Equity Research Inc. owned approximately 0.19% of Masimo Corporation worth $8,476,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently added to or reduced their stakes in the company. New York State Common Retirement Fund grew its position in Masimo Corporation by 7.8% during the 3rd quarter. New York State Common Retirement Fund now owns 63,410 shares of the medical equipment provider’s stock worth $5,489,000 after acquiring an additional 4,594 shares during the last quarter. Retirement Systems of Alabama grew its position in Masimo Corporation by 3.5% during the 3rd quarter. Retirement Systems of Alabama now owns 89,157 shares of the medical equipment provider’s stock worth $7,717,000 after acquiring an additional 2,977 shares during the last quarter. HL Financial Services LLC bought a new stake in Masimo Corporation during the 3rd quarter worth approximately $2,850,000. Jennison Associates LLC grew its position in Masimo Corporation by 69.2% during the 3rd quarter. Jennison Associates LLC now owns 19,712 shares of the medical equipment provider’s stock worth $1,706,000 after acquiring an additional 8,062 shares during the last quarter. Finally, Swiss National Bank grew its position in Masimo Corporation by 1.9% during the 3rd quarter. Swiss National Bank now owns 81,300 shares of the medical equipment provider’s stock worth $7,037,000 after acquiring an additional 1,500 shares during the last quarter. Institutional investors own 84.94% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Los Angeles Capital Management & Equity Research Inc. Has $8.48 Million Stake in Masimo Corporation (MASI)” was first reported by Daily Political and is owned by of Daily Political. If you are accessing this story on another site, it was illegally stolen and reposted in violation of United States & international copyright laws. The legal version of this story can be accessed at https://www.dailypolitical.com/2017/11/19/los-angeles-capital-management-equity-research-inc-has-8-48-million-stake-in-masimo-corporation-masi.html.

A number of research firms recently commented on MASI. BidaskClub lowered Masimo Corporation from a “buy” rating to a “hold” rating in a research report on Monday, July 31st. BTIG Research upgraded Masimo Corporation from a “neutral” rating to a “buy” rating and set a $100.00 price target on the stock in a research report on Monday, August 14th. Zacks Investment Research lowered Masimo Corporation from a “buy” rating to a “hold” rating in a research report on Tuesday, October 3rd. Finally, Stifel Nicolaus restated a “buy” rating and set a $108.00 price target (up from $105.00) on shares of Masimo Corporation in a research report on Thursday, August 3rd. One analyst has rated the stock with a sell rating, three have assigned a hold rating and five have issued a buy rating to the company’s stock. Masimo Corporation currently has an average rating of “Hold” and a consensus price target of $97.17.

In related news, EVP Yongsam Lee sold 13,976 shares of the firm’s stock in a transaction on Thursday, November 9th. The stock was sold at an average price of $89.43, for a total transaction of $1,249,873.68. Following the sale, the executive vice president now owns 74,000 shares of the company’s stock, valued at approximately $6,617,820. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Steven Barker sold 10,000 shares of the firm’s stock in a transaction on Wednesday, November 1st. The stock was sold at an average price of $90.00, for a total value of $900,000.00. Following the sale, the director now directly owns 73,249 shares in the company, valued at approximately $6,592,410. The disclosure for this sale can be found here. In the last three months, insiders sold 28,976 shares of company stock worth $2,599,324. 16.60% of the stock is currently owned by company insiders.

Masimo Corporation (NASDAQ:MASI) opened at $86.55 on Friday. The company has a market capitalization of $4,472.13, a price-to-earnings ratio of 33.16, a price-to-earnings-growth ratio of 2.92 and a beta of 0.75. Masimo Corporation has a 12-month low of $60.31 and a 12-month high of $104.71.

Masimo Corporation (NASDAQ:MASI) last announced its quarterly earnings data on Tuesday, October 31st. The medical equipment provider reported $0.70 EPS for the quarter, beating the Zacks’ consensus estimate of $0.53 by $0.17. The firm had revenue of $193.69 million for the quarter, compared to analyst estimates of $189.01 million. Masimo Corporation had a return on equity of 22.17% and a net margin of 45.83%. The business’s quarterly revenue was up 15.6% compared to the same quarter last year. During the same period last year, the company earned $0.52 EPS. equities analysts expect that Masimo Corporation will post 2.95 EPS for the current year.

About Masimo Corporation

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.

Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Corporation (NASDAQ:MASI).

Institutional Ownership by Quarter for Masimo Corporation (NASDAQ:MASI)

Receive News & Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related companies with MarketBeat.com's FREE daily email newsletter.